Cargando…
Network modeling of kinase inhibitor polypharmacology reveals pathways targeted in chemical screens
Small molecule screens are widely used to prioritize pharmaceutical development. However, determining the pathways targeted by these molecules is challenging, since the compounds are often promiscuous. We present a network strategy that takes into account the polypharmacology of small molecules in o...
Autores principales: | Ursu, Oana, Gosline, Sara J. C., Beeharry, Neil, Fink, Lauren, Bhattacharjee, Vikram, Huang, Shao-shan Carol, Zhou, Yan, Yen, Tim, Fraenkel, Ernest |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5638242/ https://www.ncbi.nlm.nih.gov/pubmed/29023490 http://dx.doi.org/10.1371/journal.pone.0185650 |
Ejemplares similares
-
Dual kinase-bromodomain inhibitors for rationally designed polypharmacology
por: Ciceri, Pietro, et al.
Publicado: (2014) -
The kinase polypharmacology landscape of clinical PARP inhibitors
por: Antolin, Albert A., et al.
Publicado: (2020) -
Exploiting kinase polypharmacology for nerve regeneration
por: Al-Ali, Hassan, et al.
Publicado: (2016) -
Targeted polypharmacology: Discovery of dual inhibitors of tyrosine and phosphoinositide kinases
por: Apsel, Beth, et al.
Publicado: (2008) -
Dual protein kinase and nucleoside kinase modulators for rationally designed polypharmacology
por: Hammam, Kahina, et al.
Publicado: (2017)